The global demand for Growth Hormone Market is presumed to reach the market size of nearly USD XX MN by 2028 from USD XX MN in 2021 with a CAGR of XX% under the study period 2022 - 2028.
Growth hormone or human growth hormone (HGH) is also identified as somatotropin. HGH is secreted by the pituitary gland, present inside the human brain. This hormone is responsible for stimulating growth in children and adolescents. It boosts bone and muscle growth and plays an important role in cell regeneration and reproduction, metabolism, body composition and cell repair. However, growth hormone deficiency occurs when the pituitary gland does not release the required level of HGH, resulting in short height and delayed puberty. Brain injury or certain genetic disorders namely, Turner syndrome and Prader-Willi syndrome may cause HGH deficiency. However, this deficiency can be treated by administering artificial growth hormones.
Market Dynamics
The global HGH market seems to be quite impressive due to surge in HGH deficiency diseases and increasing application of growth hormones for treating problems like idiopathic short stature, small for gestational age and Turner syndrome. Other key market drivers are initiatives taken by firms and government bodies for increasing awareness about growth hormone deficiencies and its treatment. Factors like upsurge in FDA approvals and substantial investment by drug manufacturers for R&D activities for developing novel drugs are also expected to drive the market significantly. However, side effects like muscle aches, fluid retention and joint pain and the high cost associated with artificial HGH will hinder HGH market.
The research report covers Porter's Five Forces Model, Market Attractiveness Analysis, and Value Chain analysis. These tools help to get a clear picture of the industry's structure and evaluate the competition attractiveness at a global level. Additionally, these tools also give an inclusive assessment of each segment in the global market of growth hormone. The growth and trends of growth hormone industry provide a holistic approach to this study.
Market Segmentation
This section of the growth hormone market report provides detailed data on the segments at country and regional level, thereby assisting the strategist in identifying the target demographics for the respective product or services with the upcoming opportunities.
By Product
By Application
- Growth Hormone Deficiency
- Idiopathic Short Stature
- Turner Syndrome
- Small For Gestational Age
- Prader-Willi Syndrome
- Others
By Distribution Channel
- Hospital Pharmacy
- Retail Pharmacy
- Online Medstores
Regional Analysis
This section covers the regional outlook, which accentuates current and future demand for the Growth Hormone market across North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. Further, the report focuses on demand, estimation, and forecast for individual application segments across all the prominent regions.
Global Growth Hormone Market Share by Region (Representative Graph)
The research report also covers the comprehensive profiles of the key players in the market and an in-depth view of the competitive landscape worldwide. The major players in the growth hormone market include Novo Nordisk A/S, Pfizer Inc., Novartis AG, Eli Lily And Company, Merck KGaA, Ipsen S.A., Anhui Anke Biotechnology Co., Ltd, LG Chem Ltd., Ferring B.V., and Genetech Inc. This section consists of a holistic view of the competitive landscape that includes various strategic developments such as key mergers & acquisitions, future capacities, partnerships, financial overviews, collaborations, new product developments, new product launches, and other developments.
In case you have any custom requirements, do write to us. Our research team can offer a customized report as per your need.